Results 61 to 70 of about 54,287 (293)

DEATHS FROM PRESCRIPTION DRUG ABUSE IN FAISALABAD

Journal of University Medical & Dental College, 2018
: BACKGROUND: Prescription drugs are used to treat the humanity to reduce the ailments but these drugs when used irrationally either by the prescribing doctor or misused by the patient, may lead to death.
Muhammad Naeem, Mobin Inam Pal, Humera Parveen et al.   +2 more
doaj  

Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States.

PLoS ONE, 2016
BackgroundTherapeutic use and abuse of prescription opioids in the United States increased substantially between 1990 and 2010. The Centers for Disease Control estimated deaths related to pharmaceutical opioids reached nearly 19,000 in 2014.
Janetta L Iwanicki, S Geoff Severtson, Heather McDaniel, Andrew Rosenblum, Chunki Fong, Theodore J Cicero, Matthew S Ellis, Steven P Kurtz, Mance E Buttram, Richard C Dart   +9 more
doaj   +1 more source

Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness

Journal of Infection and Public Health, 2020
Prescription Drug Monitoring Program (PDMP) is an electronic database that tracks the prescriptions of controlled drugs with its aims to combat the incidence of drug abuse.
Fahd Alogaili, Norjihan Abdul Ghani, Nordiana Ahmad Kharman Shah   +2 more
doaj   +1 more source

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, Elvira Bramon, Helen Cross, Natalie Curley, Sarah Curran, Helen Davies, Jana De Villiers, William Evans, Bernhard Frank, Alice Groves, Judith Hayward, Jon Higham, Dyfrig A. Hughes, Shwe Sin Kyaw, Anthony G. Marson, Ailsa McLellan, Seth Mensah, Francis O'Neill, Jane Sargison, Sanjay M. Sisodiya, Jill Swan, Joanna M. Zakrewska, Munir Pirmohamed   +24 more
wiley   +1 more source

Prescription Drug Abuse

, 2020
This informative paper analyzed the prescription drug abuse epidemic among the adolescent population through a holistic lens. The prescription drug abuse epidemic has been identified as a national and community healthcare issue due to the harmful ...
Bray, Laura, Lauer, Olivia Ann
core  

Prescription Drug Abuse on College Campuses

, 2021
2021 Celebration of Student Research and Creativity presentation"Prescription drug abuse is an epidemic that persists across all populations. It is the use of medication without a prescription from a healthcare provider, for nonmedical purposes, or in ...
Childs, Isabel
core  

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

Ohio Prescription Drug Abuse Task Force: Final Report Task Force Recommendations

, 2010
On April 2, 2010, Governor Ted Strickland signed Executive Order 2010-4S, establishing the Ohio Prescription Drug Abuse Task Force (the “Task Force”). The Task Force was created to develop a coordinated and comprehensive approach to Ohio’s prescription ...
Ohio Prescription Drug Abuse Task Force
core  

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine

ClinicoEconomics and Outcomes Research, 2020
Louis F Rossiter, 1 Winghan Jacqueline Kwong, 2 Elizabeth Marrett 2 1The College of William and Mary, Williamsburg, VA 23187, USA; 2US Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ 07920, USACorrespondence: Elizabeth MarrettUS Medical ...
Rossiter LF, Kwong WJ, Marrett E
doaj